Session Datesort descending
Anti-PLA2R Antibody Levels and Clinical Risk Factors for Treatment Nonresponse in Membranous Nephropathy 09/15/2023 - 12:00pm to 1:00pm
Associations between Net Gastrointestinal Alkali Absorption, 24-Hour Urine Lithogenic Factors, and Kidney Stones 09/29/2023 - 12:00pm to 1:00pm
Frailty and Cardiovascular Outcomes in Adults With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study 10/20/2023 - 12:00pm to 1:00pm
Renin–Angiotensin–Aldosterone System Blockade after AKI with or without Recovery among US Veterans with Diabetic Kidney Disease 11/10/2023 - 12:00pm to 1:00pm
Comparative Safety of Antidepressants in Adults with CKD 12/08/2023 - 12:00pm to 1:00pm
Estimated Lifetime Cardiovascular, Kidney and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Non-steroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria 12/22/2023 - 12:00pm to 1:00pm
Comparison of Short-Term Outcomes in Kidney Transplant Recipients from SARS-CoV-2–Infected versus Noninfected Deceased Donors 01/19/2024 - 12:00pm to 1:00pm
Severe Hyponatremia Correction, Mortality, and Central Pontine Myelinolysis 02/09/2024 - 12:00pm to 1:00pm
Mendelian Randomization Analysis of Genetic Proxies of Thiazide Diuretics and the Reduction of Kidney Stone Risk 02/23/2024 - 12:00pm to 1:00pm
Empagliflozin in Heart Failure: Regional Nephron Sodium Handling Effects 03/15/2024 - 12:00pm to 1:00pm

Pages